Joined June 2010
27 Photos and videos
Tom Hellyer retweeted
5
12
758
Tom Hellyer retweeted
We're hiring! The NIHR-funded @SHORTERtrial seeks a Senior Research Fellow for the Process Evaluation. A great opportunity for qualitative/mixed-methods researchers to step into a senior role and develop leadership skills @EdinburghNapier Apply now ⬇️ jobs.ac.uk/job/DLA526/senior…

1
7
7
731
Tom Hellyer retweeted
#CCRdownunder24 congress just started 1st study ADAPT-Sepsis published in @JAMA_current Procalcitonin guided protocol ⬇️ antibiotic treatment duration by 1day (significant) but 28-day mortality non-sign⬆️by 7% (relative risk): from 19.4 to 20.9% jamanetwork.com/journals/jam…
4
19
30
5,018
Tom Hellyer retweeted
9 Dec 2024
Published in JAMA with #CCRdownunder: In critically ill adults with suspected sepsis, antibiotic regimens were safely reduced when guided by measurement of procalcitonin but not by C-reactive protein. @CritCareReviews ja.ma/41t10TE
2
117
294
55,297
Tom Hellyer retweeted
7d is not a country mile away from standard care in the UK. Recognising microbiological cure is hard. Antibiotics are not without harm. Try @SHORTERtrial @hellyerthomas
21 Nov 2024
Original Article: Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections (BALANCE) nej.md/3Z5bTJD #CCCF2024 | @CCCForum
2
6
357
Tom Hellyer retweeted
20 Nov 2024
Presented at #CCCF2024: In the BALANCE randomized clinical trial, patients with bacteremia were assigned to 7 or 14 days of appropriate antimicrobial therapy, and 7 days of therapy was found to be noninferior to 14 days. Full trial results: nej.md/3Z5bTJD
5
82
248
73,989
Tom Hellyer retweeted
UK critical care could offer @SHORTERtrial to patients. @hellyerthomas
This has been our practice for several years now, good to see it confirmed in a trial. Question is, do we need 7 days? Next trial I would like is either a fair bit shorter or adaptive depending on patient condition (and if we could speed up blood culture- pathogen clearance)
3
8
1,041
Tom Hellyer retweeted
2 Oct 2024
This is what I gleaned the working group recognised and will seek to address (1) the infeasibility of training in academia and two medical specialities (2) academia now linked to pay penalties through slower progression and diminished merit awards….
1 Oct 2024
I’m at an NIHR Senior Investigators meeting where Patrick Chinnery presented on an academic clinical careers and a forthcoming report. Looks v promising from his short presentation.
7
16
40
27,820
Tom Hellyer retweeted
More posters today from trial managers Gillian Watson and @AGrSwain Come and find out more about recruitment during COVID-19 and lessons in running dental trial @enhanced_trial #ICTMC2024
1
4
15
894
Tom Hellyer retweeted
Come and see @Dean_Allerton to learn more about #eConsent in the @IBDResponse study #ICTMC2024
3
1
12
423
7 days in the week. 5 digits on your hand. So naturally antibiotic courses are multiples of 7 or 5 🤔. @SHORTERtrial large @NIHRresearch funded trial investigating short (5 day) course of antibiotics vs SoC in sepsis. Challenging the 'week's course' dogma.
Challenging dogma if evidence non‑existent, weak, outdated part II 💊give a week’s course of ABT 🍬standardized management for DKA 🫀icarbonate improves contractility in severe acidosis ⚗️hypophosphatemia needs correction 🔓rdcu.be/dVaRu Part I 🔓rdcu.be/dVaUx
5
11
651
Tom Hellyer retweeted
New data released today in @TheLancet shows that without urgent action, antimicrobial resistance could kill 39 million people by 2050. Deaths and inequities from the global antibiotic emergency are increasing and now is the time to take urgent action. thelancet.com/journals/lance…
7
144
192
31,718
Tom Hellyer retweeted
NHIP Academy was delighted to support eight exceptional researchers throughout their application process to be successfully awarded the new Senior Clinical and Practitioner Research Award (SCPRA) from the @NIHRresearch (NIHR). Read the full story here: newcastlehealthinnovation.or…
6
32
11,344
Tom Hellyer retweeted
There is a crisis in clinical academia in the UK. We talk of the need to expand medical schools, embed research into the NHS to improve care, & the importance of a vibrant life sciences sector for the economy of the UK, & yet we seem unable to tackle the underlying issues 1/9
22
248
539
281,407
Amazing effort by the @SHORTERtrial sites and by the @NclCTU team to get off to such a good start. Keep on going!
19 sites open and 168 patients have had the opportunity to participate in research! Wow! Incredible work by all the @SHORTERtrial sites. Keep up the good work. More sites to open soon. 🎯👏👏👏 @NIHRresearch @NclCTU @UniofNewcastle @hellyerthomas
1
1
5
273
Tom Hellyer retweeted
19 sites open and 168 patients have had the opportunity to participate in research! Wow! Incredible work by all the @SHORTERtrial sites. Keep up the good work. More sites to open soon. 🎯👏👏👏 @NIHRresearch @NclCTU @UniofNewcastle @hellyerthomas
1
7
428
Tom Hellyer retweeted
4 Jul 2024
❌ We NEVER want to see a sign like this ever again. ❌ The next government has the power to make that happen. They can end the need for food banks.
62
3,094
9,112
310,787
Tom Hellyer retweeted
#A2Btrial results presentation is now live! Dexmedetomidine vs Clonidine vs Propofol for ICU sedation criticalcarereviews.com #CCR24 @Ed_TimWalsh Chris Weir & Ranjit Lall

12
43
9,597
Tom Hellyer retweeted
Delighted to review #BLINGIII examining continuous v intermittent infusion in critically ill patients with sepsis, at #CCR24. While this one sentence JAMA summary is technically correct, the full data and discussion at #CCR24 provides a different perspective. Here is why..1/
12 Jun 2024
BLING III: In critically ill patients with sepsis, continuous vs intermittent β-lactam antibiotic infusions did not significantly reduce 90-day mortality. ja.ma/3VEouCa #CCR24
3
23
72
35,748